Form 8-K - Current report:
SEC Accession No. 0001437749-24-021108
Filing Date
2024-06-24
Accepted
2024-06-24 17:24:09
Documents
16
Period of Report
2024-06-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20240624_8k.htm   iXBRL 8-K 55370
2 EXHIBIT 10.1 ex_691933.htm EX-10.1 223201
3 EXHIBIT 10.2 ex_691934.htm EX-10.2 82394
  Complete submission text file 0001437749-24-021108.txt   556624

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240624.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240624_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240624_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240624_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240624_8k_htm.xml XML 2827
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 241065391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)